MedPath

Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit

Terminated
Conditions
Covid19
Critically Ill
Interventions
Other: No intervention (Retrospective Cohort Observational)
Registration Number
NCT04805645
Lead Sponsor
Clinical Research Centre, Malaysia
Brief Summary

Studying clinical characterization of critically ill COVID-19 patients in a single center Studying Risk factors for Day 28 Mortality in COVID-19 patients admitted to intensive care unit

Detailed Description

An observational study looking into clinical characterization of the novel Coronavirus Disease 2019 (COVID-19) in patients admitted, critically ill, into Intensive Care Unit of Hospital Queen Elizabeth between 1st October 2020 until 31st January 2021. Analysis also would be looking into the risk factors into Day 28 mortality of these patients

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All patients admitted to the ICU in Hospital Queen Elizabeth, Kota Kinabalu between 1st October 2020 until 31st January 2021
  • Confirmed COVID-19 Positive using RT-PCR or RTK-Ag either before or during admission in ICU
Exclusion Criteria
  • Patients that were admitted in ICU suspected to have COVID-19 and died in ICU which subsequently to be COVID-19 negative

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-SurvivorsNo intervention (Retrospective Cohort Observational)Participants who had Critically-ill COVID-19 and admitted to the Intensive Care Unit which died before or on day 28 post ICU admission
Primary Outcome Measures
NameTimeMethod
Mortality28 days

Died before or on Day 28 after ICU admission

Secondary Outcome Measures
NameTimeMethod
Oxygen supplementation requirementday 28

Requirement of oxygen supplementation on day 28 after icu admission

Trial Locations

Locations (1)

Hospital Queen Elizabeth

🇲🇾

Kota Kinabalu, Malaysia

© Copyright 2025. All Rights Reserved by MedPath